Clinical Trial Update: Ipilimumab Combined With a Stereotactic Radiosurgery in Melanoma Patients With Brain Metastases [Phase 2]

View source ↗

Summary

This phase 2 trial evaluates ipilimumab in combination with stereotactic radiosurgery for melanoma patients with brain metastases. The study status is completed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastases
• Melanoma

Drugs mentioned

• ipilimumab (ipilimumab)

Snippet

Sponsor: University Hospital, Lille | Conditions: Melanoma, Brain Metastasis | Phase 2 | Status: COMPLETED